Tag: Killer Acquisitions
The No Kill Zone: The Other Side of Pharma Acquisitions
In recent years there have been calls for increased scrutiny and enforcement of acquisitions by incumbent pharmaceutical firms of potentially competitive pipeline products. A...
Beyond Killer Acquisitions: Are There More Common Potential Competition Issues in...
How common are killer acquisitions in tech and are there alternative theories of harm that are likely to arise more frequently? We apply a...
Remember Stacker? Another Look at “Killer” Acquisitions in the Digital Economy
Many acquisitions of startups by incumbents in the digital economy have resulted in a significant boost to marketplace recognition and interest in innovative, but...
The Jury Is Out: An Assessment of Proposed Reforms to Australia’s...
Recently, competition authorities globally have been advocating for law reform to enhance their enforcement powers in relation to so called "killer acquisitions." In July...
Assessing “Killer Acquisitions”: An Assets and Capabilities-Based View of the Start-Up
Killer acquisitions have come under the eye of the antitrust community. However, the issue has not always been discussed in a systematic way and...
